# Personalis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/personalis

- Industry: Biotechnology
- Headquarters: Menlo Park, US
- Website: www.personalis.com
- Total disclosed funding: $57M
- Latest round: Series C (Dec 16, 2014)
- Investors on record: 5

## About

Based in the US, Personalis Inc. is a biotechnology firm specializing in advanced diagnostics and personalized cancer treatment solutions through innovative genomic analysis.Personalis Inc. focuses on cancer care, providing diagnostic solutions to detect cancer recurrence. Founded in 2011 in Menlo Park, California, the company has raised a total of USD 150.10 mn across its funding rounds, with the latest being a Private Placement/Follow on of USD 150.10 mn in January 2021. Co-founded by Atul Butte, Euan Ashley, and Russ Altman, the company is led by CEO John West.Personalis specializes in advanced cancer diagnostics, with its flagship product, the NeXT Personal®, utilizing ultra-sensitive circulating tumor DNA (ctDNA) analysis to detect cancer recurrence. This technology enables earlier interventions, especially for early-stage cancers like breast and lung cancers. The company serves oncologists, healthcare institutions, and biopharma partners across North America and Europe, providing crucial information for treatment decisions.In the most recent fiscal year 2024, Personalis reported revenue of USD 84.61 mn, alongside an EBITDA of USD -68.27 mn. The company's revenue is derived from its diagnostic testing services, primarily the NeXT Personal® assay, which operates through service agreements with healthcare providers and biopharmaceutical firms.Looking ahead, Personalis aims to expand its operations through new product launches and market penetration. They plan to introduce additional assays and enhance their service offerings by 2025. The recent funding of USD 150.10 mn will be utilized to support these initiatives, facilitating the development of innovative diagnostics and expanding their market presence in North America and Europe.

## Funding rounds

- Series C, Dec 16, 2014, $30M — Abingworth, Lightspeed Venture Partners, Mohr Davidow Ventures
- Series B, Oct 1, 2013, $22M — Abingworth, Lightspeed Venture Partners, Mohr Davidow Ventures, Wellington Shields & Co. LLC
- Series A, Aug 4, 2011, $5M — Abingworth, Lightspeed Venture Partners, Mohr Davidow Ventures, Stanford University

## Investors

- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A, Series B, Series C
- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series A, Series B, Series C
- Mohr Davidow Ventures (https://capitalatlas.ai/funds/mohr-davidow-ventures) — Series A, Series B, Series C
- Stanford University — Series A
- Wellington Shields & Co. LLC — Series B